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Metalloproteinases are thought to be important for tumor 
invasion and metastasis. We used in situ hybridization with 
35S-labeled cRNA probes to localize sites of expression for 
92-kDa type IV collagenase mRNA in sections of nodular 
basal cell carcinoma. Positive signal for 92-kDa type IV col-
lagenase mRNA was detected in eosinophilic granulocytes 
within inflammatory infiltrates surrounding the tumor nod-
ules. Eosinophils, however, were not adjacent to tumor cells, 
suggesting that metalloenzyme production by these granulo-
cytes in this disease may be targeted more to stromal compo-
nents than to remodeling or destruction of the basement 
lamina. The identity of the eosinophils was confirmed by cell 
morphology and specific histochemical staining. No resident 
For invasion and metastasis, neoplastic cells interact with and migrate through the surrounding stroma. These processes most likely involve proteolytic activity, and one hypothesis is that tumor cells secrete matrix-degrad-ing enzymes or induce proteinase expression in resident 
or migratory cells [1] . The gene family of metalloenzymes and their 
inhibitors are recognized as playing an important role in tumor 
growth [2]. Metalloproteinases are a structurally related family of 
enzymes and, collectively, these enzymes can degrade most base-
ment membrane and stromal proteins that would be encountered by 
an invasive tumor [3]. 
Several recent in vitro studies have demonstrated that activation 
of metalloproteinases stimulates tumor-cell invasion, whereas inhi-
bition of metalloproteinase activity prevents tumor growth [4,5]. 
For example, ablation of endogenous production of tissue inhibitor 
of metalloproteinases (TIMP) with antisense RNA confers oncoge-
nicity to Swiss 3T3 cells [6]. Invasion of epithelial tumors probably 
involves degradation and remodeling of basement membrane and 
the surrounding stromal matrix [7]. Interestingly, the metallopro-
teinases that degrade these structural proteins are, to a large extent, 
secreted by fibroblasts (interstitial collagenase, 72-kDa type IV col-
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or other migratory cells were positive for enzyme mRNA in 
these samples. Signal specificity for in situ hybridization was 
shown by a duplication of the results with complementary 
oligomeric probes and by a lack of signal in sections hybrid-
ized with a sense RNA probe or nonspecific oligomer. No 
signal for 92-kDa type IV collagenase mRNA was detected in 
circulating eosinophils or in eosinophils associated with 
Hodgkin's lymphoma. These data suggest that eosinophils 
migrate into the dermis and express type IV collagenase in 
response to basal cell carcinoma and that this process may 
have a role in tumor growth. ] Invest Dermatol 99:497 -503, 
1992 
lagenase, stromelysins) and by inflammatory cells (neutrophil colla-
genase, 92-kDa type IV collagenase) [3,8,9]. This suggests that 
tumor cells may mediate a recruitment of metalloproteinase-ex-
pressing cells or induce metalloproteinase expression in resident and 
migratory cells to assist in invasion. Indeed, conditioned medium 
from cultured basal carcinoma cells stimulates fibroblasts to degrade 
both fibrillar [10,11] and type IV collagens [12], and expression of 
stromelysin-3 is induced in stromal cells surrounding breast carcino-
mas. [13] . 
Basal cell carcinomas are slow-growing, cutaneous epithelial 
tumors that are locally invasive but generally do not metastasize. 
The connective tissue adjacent to tumor islands is typically altered 
and associated with a proliferation of fibroblasts and inflammation. 
In the process of growing, basal cell carcinomas must remodel 
their basement membrane and the surrounding dermal matrix. Be-
cause of its ability to degrade components of both the basement 
membrane (type IV collagen) and dermal stroma (elastin, types V 
and VII collagen, and collagenase-cleaved fibrillar collagen or gela-
tin) [14 - 16] and because of its established association with invasion 
[17 -19], we examined the expression of 92-kDa type IV collagen-
ase in samples of nodular basal cell carcinoma. Using in situ hybrid-
ization, we have demonstrated that active expression of 92-kDa 
type IV collagenase is limited to eosinophils in inflammatory infil-
trates surrounding nodular basal cell carcinomas. Our findings are 
the first example of type IV collagenase gene expression by eosino-
phils. 
MATERIALS AND METHODS 
Tissues Formalin-fixed, paraffin-embedded archival specimens 
taken during surgery were obtained from the Department of Pat hol-
ogy, Washington University School of Medicine and from the De-
partment of Dermatology, Karolinska Hospital. Pathologic assess-
ment determined that all basal cell carcinomas were of the 
nodular-ulcerative form. Human blood was sampled from normal 
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volunteers, and the polymorphonuclear granulocyte fraction, 
which contains neutrophils and eosinophils, was isolated by centrif-
ugation through 13.8% sodium metrizoate, 8.0% Dextran 500 (Po-
Iymorphprep, Accurate Chemical and Scientific Corp., Westbury, 
NY) according to instructions from the manufacturer. Granulo-
cytes were counted with a hemocytometer, diluted in phosphate-
buffered saline (PBS) (10 roM potassium phosphate, 150 roM 
NaCI, pH 7.4) containing 1 % calf serum to 2 X 106 cells/ml and 
centrifuged onto slides at 1000 rpm for 10 min. The slides were 
fixed for 5 min in PBS-buffered 10% formalin, washed twice in 
PBS, and processed for in situ hybridization as described below. For 
identification of eosinophils, sections were stained with Luna's eo-
sinophilic granule stain [20] . 
Tissue Preparation and In Situ Hybridization In situ hybrid-
ization was done essentially as described [21]. Briefly, sections were 
cut at 5 fl.m, dried at 42 °C on Superfrost Plus slides (Fisher Scien-
tific), deparaffinized in xylene, dehydrated through graded ethan-
ols, and rehydrated in PBS. To minimize accumulated exogenous 
RNase contamination on archival samples, about five sections were 
cut from each block and discarded. Sections from paraffin blocks, 
but not isolated cytospun cells, were treated with 1 fl.g/ml nuclease-
free proteinase K (Sigma, St. Louis, MO) to loosen the constraints 
of intracellular cross-links caused by fixation. All samples were 
washed in freshly prepared 0.1 M triethanolamine buffer contain-
ing 0.25% acetic anhydride to reduce potential nonspecific binding 
sites [22]. 
For RNA probes, sections were covered with a sufficient volume 
(about 25 to 50 fl.1) of hybridization buffer containing 50% deion-
ized formamide, 2 X standard saline-citrate buffer (SSC) (1 X is 
150 roM sodium chloride, 15 roM sodium citrate, pH 7.0),20 roM 
Tris-HCI, pH 8.0, 1 X Denhardt's solution, 1 roM EDTA, 10% 
dextran sulfate, 100 roM dithiothreitol (OTT), 0.5 mg/ml yeast 
tRNA and 104 cpm/fl.1 oP5S-labeled RNA. For oligomeric probes, 
sections were hybridized with 10 roM Tris-HCI, pH 7.0,2 X SSC, 
1 mg/ml denatured calf thymus DNA, 2.0 mg/ml yeast tRNA, 
10 X Denhardt's solution, 0.5 units/fl.1 RNasin (Promega, Madi-
son, WI), 50 roM p-mercaptoethanol containing 105 cpm/fl.l of 
each 35S-labeled 92A and 92B oligomers (see below). To retain the 
hybridization solution over specimens, sections were covered with 
siliconized, autoclaved coverslips sealed with a 1 : 1 mixture of rub-
ber cement and petroleum ether. Sections were incubated at 55°C 
(RNA probes) or 50°C (oligomers) in a humidified chamber. After 
hybridization, slides were washed under stringent conditions as de-
scribed [21] except that 10 roM OTT was substituted for 25 roM 
p-mercaptoethanol in the wash solutions. For sections hybridized 
with RNA probes, nonspecific binding was reduced by incubating 
slides in 0.5 M NaCI, 10 roM Tris-HCl, pH 8.0, 1 roM EDTA 
containing 50 fl.g/ml RNase-A (Sigma) at 37°C for 1 h. Washed 
slides were dipped in Kodak NTB-2 emulsion prediluted 1 : 1 with 
distilled water and processed for autoradiography as described [21]. 
After development of the photographic emulsion, slides were 
stained with hematoxylin-eosin. 
Preparation of RNA Probes A full-length cDNA (92L) and a 
560-bp BamHI.- XbaI fragment (92S) of its 3' end were subcloned in 
Bluescript KS transcription vectors (Stratagene, La Jolla, CA) and 
generously supplied by Dr. Gregory I. Goldberg, Washington Uni-
versity. The constructs were linearized to allow transcription over 
the same 560-bp region of the 92-kDa type IV collagenase cDNA 
but in opposite directions. This part of the cDNA encodes for the 
carboxyl terminus of the 92-kDa type IV collagenase, which dis-
plays considerable sequence divergence from similar domains of 
other metalloproteinases [8]. By this design, transcription with the 
92L construct produced antisense RNA, and transcription with the 
92S construct produced sense RNA. In vitro transcribed RNA was 
labeled with a[35S]UTP (> 1200 Ci/mmole; NEN Boston, MA) 
under conditions recommended by and with reagents from Pro-
mega except that the transcription reaction was extended to 4 h to 
allow for the relatively inefficient incorporation of sulfated ribonu-
cleotides. Calculated probe specific activities were between 108 and 
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109 dpm/fl.g. For Northern hybridization, RNA probes were la-
beled with a[32P]UTP. RNA probes were purified and stored as 
described [21]. 
Oligomer Preparation Two oligomers complementary to 92-
kDa type IV collagenase mRNA were synthesized on an ABI 381A 
DNA synthesizer using p-cyanoethyl phosphoramidite chemistry. 
Oligomers were desalted by repeated ethanol precipitation and de-
natured in 100% formamide. Full-length molecules were extracted 
from gel pieces after electrophoresis through 20% acrylamide con-
taining 7 M urea [23]. These oligomers are complementary to 
unique sequences within the region encoding the carboxy terminus 
of the 92-kDa enzyme. One oligomer, 92A, is 23 nucleotides (5' 
ACCGGACTCAAAGGCACAGT AGT 3') and is complementary 
to bases 1532 - 1554. The other, 92B, is 25 nucleotides (5' 
CAGAAA TAGGCTTTCTCTCGGT ACT 3') and is complemen-
tary to bases 2015-2039 [8]. Based on percent GC, length, and 
hybridization conditions, the calculated T m was similar for both 
probes (92A = 65 ° C; 92B = 64 ° C). Analysis with database se-
quences revealed complete homology with only 92-kDa enzyme 
mRNA. Both oligomers (30 pmol) were labeled in separate reac-
tions at their 3' end witha[35SJdGTP (800-1500 Ci/mmol; NEN) 
as described [21]. Under the reaction conditions used, an average of 
1.5 [35S]dGMP molecules are added per oligomer. These oligomers 
A 
92L 92S 
B 
92L 92S 
- 285 
-185 
Figure 1. Northern hybridization demonstrating specificity of probes for, 
92-kDa type IV collagenase mRNA. Expression of mRNA coding for the 
92-kDa type IV collagenase was stimulated by a 48-h exposure to 10-8 M 
12-0-tetradecanol-phorbol-13-acetate in serum-containing medium. Total 
RNA was isolated, and 10 fig per lane was resolved through agarose-for~al­
dehyde gels and transferred to nitrocellulose. For Northern hybridizatiOn, 
blots were probed with (32P)dCTP-labeled nick-translated cDNA (A) or 
with in vitro transcribed RNA probes (B). RNA probes were made frorn 
plasmid construct containing a full-length cDNA (92L) or a 560-bp frag-
ment of the 3' end (92S) and were labeled with [32P)UTP. The data demon-
strate the specificity of the full-length and truncated cD NA for 2.5-kb 
mRNA and show that only the antisense RNA probe (92L) hybridizes to the 
mRNA. 
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were designed such that a tail of two dGMP molecules continues the 
complementary base sequence of both probes for 92-kDa type IV 
collagenase mRNA [8]. A lS-nucleotide M-13 oligomeric universal 
primer was used as a negative control. 
RNA Isolation and Northern Hybridization Total RNA was 
isolated from differentiated U937 cells by guanidine isothiocyan-
ate-phenol extraction [24] . Culture conditions for and activation of 
U937 cells have been described in detail [9]. Purified total RNA was 
denatured in 1 M formaldehyde in the presence of 50% formamide 
and 50 ng/,ul ethidium bromide, resolved by electrophoresis 
through 1 % agarose and transferred passively to nitrocellulose. 
Blots were incubated with 32P-Iabeled, nick-translated 92L or 92S 
eDNA or with 32P-Iabeled antisense or sense RNA probes. Hybrid-
ization and wash conditions were as described [23] except that blots 
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hybridized with RNA probes were incubated at 55°C and were 
treated with 20,ug/ml RNase A in 2 X SSC for 30 min at room 
temperature prior to stringent washing in 0.1 X SSC at 65°C. 
RESULTS 
Probe Specificity To verify probe specificity, total RNA was 
isolated from U937 cells treated with 10-8 M 12-0-tetradecanol-
phorbol-13-acetate. U937 cells are a pre monocytic cell line that 
differentiate upon exposure to phorbol ester and upregulate their 
production of 92-kDa type IV collagenase as well as induce expres-
sion of interstitial collagenase and 72-kDa type IV collagenase [9]. 
As expected, nick-translated 92L and 92S eDNA, which contain 
sense and antisense strands, hybridized specifically to 2.s-kb 92-
kDa type IV collagenase mRNA (Fig lA). The stronger autoradio-
graphic signal on the blot hybridized with the 92L eDNA is due to 
Figure 2. In situ hybridization for 92-kDa type IV collagenase mRNA in basal cell carcinoma. Sections of basal cell carcinomas were prepared for in situ 
hybridization as described under Materials and Methods. Shown are representative specimens with either abundant (A-D) or dispersed eosinophils (E-H). 
Cancer nodules (N) are seen in both samples. A,B and E,P) Paired dark and bright field color photomicrographs of sections hybridized with 3sS-labeled 
antisense RNA probe (92L) for 92-kDa collagenase mRNA. Autoradiography was for 6 d, and sections were counterstained with H&E. Silver grains, which 
appear as bright dots under dark-field microscopy, are confined to eosinophils (arrows) . Bar, 40 p.m. e,G) High-power images of the positive cells seen in the 
panels above. The micrographs were taken slightly out of focus to allow visualization of eosinophil morphology and the overlying silver grains. Bar, 3 p.m. 
D,H) To verify the presence of eosinophils in these samples, parallel sections were stained red with Luna's eosinophilic granule stain. Same scale as e and G. 
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the longer length of this probe (2334 bp) compared to 92S (560 bp). 
Antisense RNA transcribed from the 92L construct hybridized to 
the same RNA band detected with the cDNA probes, but the 92S 
sense RNA probe did not bind to any RNA species in the sample 
(Fig 1B). 
In Situ Hybridization All archival samples were classified as 
nodular basal cell carcinoma. The tumor nodules were generally 
surrounded by inflammatory infiltrates. A total of 12 different basal 
cell carcinomas were examined and, of these, six had morphologi-
cally identifiable eosinophils within the infiltrates. Typically, the 
eosinophils were seen in small groups near to the tumor nodules. 
Four of the six tumors that contained eosinophils had positive 
signal for 92-kDa type IV collagenase mRNA in these cells (Fig 2). 
The cells expressing signal for 92-kDa collagenase mRNA had 
visible eosinophilic granules by hematoxylin and eosin (H&E) 
staining, and a bilobed nucleus was seen in many of these cells. No 
specific autoradiographic signal was seen in any resident or other 
migratory cell type. Furthermore, signal localization was verified in 
serial sections processed with Luna's eosinophilic granule stain (Fig 
2). We were not able to selectively stain eosinophils after autoradi-
ography because the photographic emulsion was stripped during 
the Luna's staining procedure. In addition, no signal for 92-kDa 
type IV collagenase mRNA was detected in any cell type in the six 
tumors without identifiable eosinophils (data not shown). Sections 
hybridized with sense RNA probe had only background autoradio-
graphic signal (Fig 3). 
There are reports of nonspecific auto radiographic signal in eosin-
ophils [25,26]. Because it is unlikely that artifacts peculiar to RNA 
probes would be duplicated with other/robes that require distinct 
hybridization .conditions, we confirme our observations using an 
alternative technique. In situ hybridization with 35S-labeled oli-
gomers demonstrated specific signal for 92-kDa type IV collagenase 
mRNA in eosinophils (Fig 4), and these results were indistinguish-
able from those obtained with the 92L cRNA probe. Sections hy-
bridized with a 35S-labeled M-13 primer, used as a nonspecificoli-
gomeric sequence, had only background autoradiographic signal 
(results not shown). 
92-kDa Type IV Collagenase Is Not Constitutively Expressed 
by Eosinophils To determine if expression of 92-kDa collagen-
ase mRNA is characteristic of circulating and tissue eosinophils, 
granulocytes isolated from normal blood of five volunteers and 
sections of lymph node biopsies from five patients with Hodgkin's 
lymphoma were examined by in situ hybridization. No auto radio-
graphic signal was detected in eosinophils present within any sam-
ple (Fig 5). These results indicate that the signal seen in eosinophils 
associated with basal cell carcinoma was not due to nonspecific 
hybridization. Furthermore, we detected no 92-kDa type IV colla-
genase mRNA, as determined by Northern hybridization, or se-
creted protein, as determined by ELISA, in circulating eosinophils 
(data not shown). These observations suggest that eosinophil mi-
gration and its expression of 92-kDa type IV collagenase are stimu-
lated in response to basal cell carcinoma. 
DISCUSSION 
Our findings ·provide the first demonstration of 92-kDa type IV 
collagenase expression by eosinophils and indicate that production 
of this enzyme by these cells is induced in response to basal cell 
carcinoma. Previous studies have demonstrated that eosinophils 
have collagenolytic and serine elastolytic activities [27 - 29], but the 
ability to degrade gelatin or type IV collagen has not been shown in 
these cells. The identity of these cells as eosinophils was based on 
both morphologic characteristics and histochemical staining, 
namely, granular, eosinophilic cytoplasm, bilobed nucleus, and reac-
tivity with Luna's stain. The specificity of these criteria has been 
verified by demonstrating that immunoreactivity for eosinophil cat-
ionic protein co-localizes with the same cells identified by Luna's 
eosinophilic granule stain [30]. 
Extracts of eosinophils have been reported to possess some metal-
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Figure 3. Specificity of hybridization signal for 92-kDa type IV collagen-
ase mRNA. Shown are bright-field photomicrographs of sections from the 
tumors shown in A -D (A) and in E-H (B) in Fig 2 hybridized with 35S_la-
beled sense RNA probe (92S). Autoradiography was for 6 d, and sections 
were counter stained with H&E. No autoradiographic signal was seen over 
eosinophils (arrows) . Bar, 10/lm. 
loproteinase activity capable of degrading collagen types I and III, 
but this extract, which was derived from circulating cells, had .no 
degradative activity for type IV collagen [28]. In agreement With 
this observation, we detected no 92-kDa type IV collagenase 
mRNA or protein in eosinophils isolated from blood of healt~y 
volunteers nor was there any detectable autoradiographic signal III 
eosinophils seen in lymph nodes taken from patients with Ho~g­
kin's lymphoma. These data strongly suggest that peripheral eoSln-
ophils associated with basal cell carcinoma are activated to produce 
92-kDa type IV collagenase. The lack of signal for 92-kDa enzyme 
mRNA in isolated cells was not due to omitting the proteinase J{ 
pretreatment during the preparation of samples for in situ hybridiza-
tion. Although protease pretreatment reportedly enhances the hy-
bridization signal, skipping this step does not prevent specific hy-
bridization. While characterizing this assay in our laboratory, we 
found that protease pretreatment only slightly increased signal 
strength on sectioned tissue and actually dislodged cytospun cell~. 
Until recently, eosinophils have been considered to be a termi-
nally differentiated cell and quiescent with respect to transcriptional 
activity [31]. Similar to neutrophils, eosinophils were thought to 
store and release products that were produced by their bone marroVI' 
precursors. Eosinophils do, however, have the capacity to synth~­
size multiple intracellular and secreted products such as eosinophlll 
cationic protein [32], transforming growth factor alpha [3~,?4 , 
CD4 protein [35], and platelet-activating factor [36]. In addlt1~n, 
eosinophils are not a homogeneous group of cells. Heterogeneity 
among normal eosinophils is evident from differences in cell den-
sity, membrane receptors, function, and chemotactic activity that 
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Figure 4. In situ hybridization with oligomeric probes for 92-kDa type IV 
collagenase mRNA. Sections from the tumors shown in A-D (A) and in 
E-H (B) in Fig 2 were hybridized with 32S-labeled oligomeric probes spe-
cific for 92-kDa type IV collagenase mRNA. As for the antisense RNA 
probe, hybridization signal was confined to eosinophils (arrows). Autoradi-
ography was for 7 d. Bar, 10 11m. 
have been described for these granulocytes [37 - 39]. In addition, 
eosinophils from patients with eosinophilia are distinct from nor-
mal cells with respect to cell-surface, lysosomal, and metabolic prop-
erties [40 l. 
If eosinophils associated with basal cell carcinoma are different 
from circulating cells, then it is possible that the dermal eosinophils 
may have been activated to express 92-kDa type IV collagenase by a 
tumor-derived factor. Indeed, large cell carcinoma of the lung pro-
duces eosinophil chemotactic factor and eosinophil colony-stimulat-
ing factor [41]. Furthermore, eosinophils are activated and undergo 
chemotaxis in response to various mediators, such as interleukin 2 
(IL-2), IL-3, IL-S, and granulocyte-macrophage colony-stimulat-
ing factor [42 -45]. With respect to the interleukins, peripheral 
eosinophilia and activation of eosinophils are selectively mediated 
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by IL-S, which is induced by IL-2 [43,46] . Furthermore, de novo 
expression of 92-kDa type IV collagenase is induced in fibroblasts 
by exposure to IL-1fi, tumor necrosis factor-a, and lymphotoxin 
[47] , but the effect of these mediators on eosinophil phenotype is 
not known. Thus, it would be interesting to determine if and where 
these cytokines are produced in response to basal cell carcinomas. It 
is likely that a cytokine cascade beginning in the growing neoplasm 
mediates multiple factors that stimulate inflammation and eosino-
phil activation. 
Our data involves detection of 92-kDa type IV collagenase 
mRNA and, thus, do not prove that eosinophils translate and secrete 
A 
. , 
Figure 5. mRNA for 92-kDa type IV collagenase was not detected in 
eosinophils in other tissues. Bright-field photomicrographs of circulating 
granulocytes (A) and a section of lymph node tissue from a patient with 
Hodgkin's lymphoma (B) that were hybridized with 3sS-labeled 92L cRNA 
probe. Autoradiographic exposure was for 14 d, and sections were counter-
stained with H&E. Eosinophils are abundant in the lymph node tissue, and 
some cells are indicated by arrows. For these experiments, five different blood 
and tissue samples were used, and representative findings are presented here. 
Bar, 9 11m. 
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92-kDa type IV collagenase. However, steady-state levels of 92-
kDa enzyme mRNA correlate with secreted protein levels in 
models of constitutive and modulated expression [47,48]. In fact, 
essentially all studies of matrix metalloproteinase gene regulation 
have established pre translational control mechanisms. Thus, eosin-
ophils may be a source of gelatinolytic activity involved in the 
matrix remodeling associated with dermal neoplastic growth. Al-
though the role of 92-kDa type IV collagenase in basal cell carci-
noma is unknown, it is unlikely that eosinophils are the sole source 
of this enzyme. Other migratory cells, particularly neutrophils, may 
secrete the enzyme but not actively produce it. 
The expression of mRNA for the 92-kDa enzyme in eosinophils 
is novel, and our future studies will focus on the proteolytic role of 
eosinophils and other cells in different forms of skin tumors. In 
addition, we will examine squamous cell carcinoma because this 
disease is often associated with eosinophils in the stroma [49]. Initial 
findings indicate that eosinophils associated with squamous cell 
tumors uniformly express mRNA for 92-kDa type IV collagenase. 
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